Citigroup »

Lyra Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $652k 124k 5.24
2023-09-30 $265k 68k 3.91
2021-03-31 $8.0k 671 11.92
2020-12-31 $14k 1.3k 11.07
2020-09-30 $4.0k 393 10.18
2020-06-30 $8.0k 723 11.07